Hydrochlorothiazide 2 mg/mL oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Hydrochlorothiazide | active | 200 mg |
| SyrSpend SF PH4 Dry, reconstituted | vehicle | q.s. to 100 mL |
- Strength
- 2 mg/mL
- Starting material
- See the study
- Container
- See the study
- Free of potentially harmful excipients for neonates.
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 60 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Room temperature | 60 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Binson G, Beuzit K, Migeot V, et al.. Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients. Pharmaceutics. 2019;11(4):190. PMID 31003500. PMC6523203. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.